CAL
JBIO

Capital Advisors Ltd’s Jade Biosciences JBIO Stock Holding History

Capital Advisors Ltd’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
6
– – ﹤0.01% 1365
2026
Q1 		$0 Hold
6
– – ﹤0.01% 1362
2025
Q4 		$0 Hold
6
– – ﹤0.01% 1347
2025
Q3 		$0 Hold
6
– – ﹤0.01% 1351
2025
Q2 		$0 Buy
+6
New +$204 ﹤0.01% 1339
2025
Q1 		– Hold
0
– – – 1332
2024
Q4 		– Hold
0
– – – 1365
2024
Q3 		– Hold
0
– – – 1362

Other funds holding JBIO

DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM
OCWP
Owl Creek Wealth Partners Denver, Colorado $342M AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM

Capital Advisors Ltd's JBIO Position: Q2 2026 in Review

Capital Advisors Ltd held its Jade Biosciences (JBIO) position steady in Q2 2026 at 6 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1365.

Capital Advisors Ltd first reported a position in JBIO in Q2 2025 and has held it in 5 quarters since. 11 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Capital Advisors Ltd held 6 shares of Jade Biosciences worth $0 as of Q2 2026.
  • Capital Advisors Ltd left its Jade Biosciences share count unchanged in Q2 2026.
  • Jade Biosciences made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1365 holding.
  • Capital Advisors Ltd first reported a position in Jade Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 11 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.